In a regulatory filing, DexCom disclosed that its CEO Kevin Sayer sold 38.5K shares of common stock on March 1st in a total transaction size of $4.23M.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on DXCM:
- Early notable gainers among liquid option names on March 2nd
- Billionaire Israel Englander Is Making Huge Bets on These 2 ‘Strong Buy’ Stocks
- DexCom selloff on Apple article should be bought, says Oppenheimer
- Baird points to elements of Apple report making it ‘less worried’ about DexCom
- Diabetes management stocks slide on report of tech giant’s breakthroughs